1.
Daza-Arnedo R, Rico-Fontalvo J, Raad-Sarabia M, Ramos-Clason E, Bohórquez-Rivero J, Montejo-Hernández J, Cabrales-Juan J, Escobar-Pacheco C, Acosta-Pérez T, Henao-Ramirez C, Cardona-Blanco M, Martinez-Avila M. Semaglutide in diabetic kidney disease: Experience in two kidney health programs in Colombia. Rev.ACE [Internet]. 2022 Sep. 21 [cited 2024 Apr. 19];9(3). Available from: https://revistaendocrino.org/index.php/rcedm/article/view/776